Event

Stryker invests $400 million in CMR Surgical and obtains exclusive acquisition option

1 reports · 1 sources

Stryker announced an investment of approximately $400 million in surgical robotics company CMR Surgical, obtaining an exclusive option to acquire all of CMR's outstanding equity in the future (subject to the terms of the agreement), and becoming the exclusive sales agent for its Versius surgical robot portfolio in the United States. The transaction is still subject to regulatory approval and the satisfaction of customary closing conditions. Under the division of responsibilities, Stryker is responsible for sales of Versius in the United States, while CMR Surgical continues to lead the development and commercialization of the product portfolio in markets outside the United States.